Disc Medicine (IRON) Times Interest Earned (2020 - 2026)
Disc Medicine (IRON) reported Times Interest Earned of -$82.37 for Q1 2026, down 84.97% year-over-year from -$548.22 in Q1 2025, and down 8.61% on a QoQ basis from -$75.84 in Q4 2025.
Disc Medicine (IRON) has 6 years of Times Interest Earned data on file, last reported at -$82.37 in Q1 2026.
- Quarterly Times Interest Earned fell 84.97% year-over-year to -$82.37 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$74.73 (up 20.57% YoY) and the FY2025 annual result came in at -$65.43, up 71.15% from the prior year.
- Times Interest Earned fell to -$82.37 in Q1 2026 per IRON's latest filing, from -$75.84 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$44.53 in Q1 2025 and bottomed at -$250.31 in Q2 2022.
- The 4-year median for Times Interest Earned is -$74.83 (2025), against an average of -$100.71.
- The widest annual swing landed in 2022, when Times Interest Earned tumbled 1591.21%; it then dropped 25.56% in 2025.
- Tracing IRON's Times Interest Earned over 4 years: stood at -$250.31 in 2022, then jumped by 75.87% to -$60.4 in 2024, then fell by 25.56% to -$75.84 in 2025, then declined by 8.61% to -$82.37 in 2026.
- Per Business Quant, the three latest IRON Times Interest Earned figures stand at -$82.37 (Q1 2026), -$75.84 (Q4 2025), and -$73.82 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - | -82.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -82.37 |
| Dec 31, 2025 | -75.84 |
| Sep 30, 2025 | -73.82 |
| Jun 30, 2025 | -67.48 |
| Mar 31, 2025 | -44.53 |
| Dec 31, 2024 | -60.40 |
| Jun 30, 2022 | -250.31 |
| Mar 31, 2022 | -150.91 |
| Dec 31, 2021 | 9.48 |
| Sep 30, 2021 | -9,225.00 |
| Jun 30, 2021 | -134.88 |
| Mar 31, 2021 | -8.92 |
| Dec 31, 2020 | -0.18 |
| Sep 30, 2020 | -3.88 |
| Jun 30, 2020 | -62.30 |
| Mar 31, 2020 | -62.95 |